STC2 and neoplasm: In soft tissue sarcoma, a signature consisting of SECTM1 and other four immune-related genes, IFIH1, CTSG, STC2, and BIRC5, could predict prognosis and the responses to ICIs23 These evidence further enhanced the correlation of SECTM1 with anti-tumor immunity.